AHEAD Intelligence Limited
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
AHEAD utilizes proprietary AI technology to develop innovative flow cytometry analysis tools, providing automatic, rapid, and standardized analysis for the international medical testing field, addressing the challenge of professional staffing shortages.
P
P
The content above was translated by Ai
Founded Year
2021
Unified Business No.
90703305
Status
Active
Number of Employees
0
Total capital
12,192,675 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
AHEAD Medicine is transforming healthcare through innovative AI technology. Our flagship Cyto-copilot platform employ AI to streamline the flow cytometry data analysis workflow. Cyto-copilot empowers healthcare providers to deliver faster, more consistent, standardized and scalable results for disease diagnosis, patient monitoring, and cell therapy quality control.
The content above was translated by Ai
